Tilray Italia
About Tilray Italia
Italian subsidiary of Canadian LP Tilray, supplying GMP-grade medical cannabis products to Italian pharmacies through the national health system.
Key Facts
- 1One of the first international LPs authorised to supply medical cannabis to Italy's SSN health system
- 2Products dispensed through hospital and community pharmacies with a medical prescription
Latest News
Tilray's Diversification Strategy Reshapes Cannabis Investment Thesis
TLRY's expansion beyond cannabis into alcohol and wellness creates new valuation framework as traditional sin stock categorization becomes outdated.
Tilray Enters European Cannabis Policy Talks as Regulatory Shift Looms
TLRY participates in EU regulatory discussions as European cannabis markets prepare for potential liberalization across multiple jurisdictions.
Canadian Cannabis Giants Show Mixed Signals Amid Market Consolidation
TLRY, CGC, and VFF navigate regulatory headwinds and operational challenges as the sector searches for sustainable growth paths in 2024.
Frequently Asked Questions
How do patients access Tilray products in Italy?
Patients need a prescription from an authorised physician; products are dispensed at licensed pharmacies.
Is Tilray Italia publicly traded?
The parent company Tilray Brands trades on NASDAQ under TLRY; the Italian subsidiary is not separately listed.
More Cannabis Companies in Rome
Cannabis Laws
Products
- Dried medical cannabis
- Cannabis oil extracts
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Rome, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY